@dansfera: Ever wonder why Series B is considered the sweet spot for biotech investment? This clip dives into the high-stakes world of biopharma funding, explaining how a rare opportunity to bypass traditional barriers led to a strategic investment in a company with robust Phase 2 data. With a massive $11.5 billion raised in the first half of the year alone, Series B is currently dominating the sector, accounting for 71% of all venture funding. It's not just about the money; it’s about backing the companies that have already cleared the toughest hurdles. #biotech #investing #venturecapital #seriesB #biopharma

dansfera

Open In TikTok:

Region: US

Monday 21 September 2026 02:52:22 GMT